Stocks · News reference
B of A Securities Maintains Buy on Minimed Group, Raises Price Target to $28
B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and raises the price target from $24 to $28.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading